Novel suction-based in vivo cutaneous DNA transfection platform

Sci Adv. 2021 Nov 5;7(45):eabj0611. doi: 10.1126/sciadv.abj0611. Epub 2021 Nov 5.

Abstract

This work reports a suction-based cutaneous delivery method for in vivo DNA transfection. Following intradermal Mantoux injection of plasmid DNA in a rat model, a moderate negative pressure is applied to the injection site, a technique similar to Chinese báguàn and Middle Eastern hijama cupping therapies. Strong GFP expression was demonstrated with pEGFP-N1 plasmids where fluorescence was observed as early as 1 hour after dosing. Modeling indicates a strong correlation between focal strain/stress and expression patterns. The absence of visible and/or histological tissue injury contrasts with current in vivo transfection systems such as electroporation. Specific utility was demonstrated with a synthetic SARS-CoV-2 DNA vaccine, which generated host humoral immune response in rats with notable antibody production. This method enables an easy-to-use, cost-effective, and highly scalable platform for both laboratorial transfection needs and clinical applications for nucleic acid–based therapeutics and vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Animals
  • COVID-19 Vaccines* / genetics
  • COVID-19 Vaccines* / immunology
  • COVID-19 Vaccines* / pharmacology
  • COVID-19* / genetics
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • DNA* / genetics
  • DNA* / immunology
  • DNA* / pharmacology
  • Male
  • Rats
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / immunology
  • Skin / immunology*
  • Suction
  • Transfection*
  • Vaccines, DNA* / genetics
  • Vaccines, DNA* / immunology
  • Vaccines, DNA* / pharmacology

Substances

  • COVID-19 Vaccines
  • Vaccines, DNA
  • DNA